Nature Made Vitamin D Tablets Recalled for Yeast and Mold
Pharmavite is recalling specific lots of Nature Made Vitamin D tablets because they may exceed specifications for yeast and mold.
The agency’s classification
FDA (Food): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves low-risk contamination (yeast/mold) without reported illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Pharmavite is recalling specific lots of Nature Made(R) Vitamin D tablets. The recall involves 30,480 units of the product, specifically the 350-count bottles with UPC 0-31604-04070-3. The affected product is identified by Lot No. 1177557 and has an expiration date of SEPT 2017.
The recall is being issued because the specific lots of Nature Made(R) Vitamin D tablets may exceed specifications for yeast and mold. The product was distributed nationwide.
Consumers who have the affected product should stop using it and follow the instructions provided by the recalling firm, Pharmavite.
The recalled product
- Product
- Nature Made(R) D3 1000IU, 350 count, UPC 0-31604-04070-3
- Manufacturer
- Pharmavite
- Category
- Drug — Dietary Supplement
- Hazard
- Affected units
- 30,480
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot No. 1177557
- exp. SEPT 2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 14 recalled by Pharmavite under a single FDA (Food) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Pharmavite
See all →- ModerateNature Made Hair Skin Nails Gummies Recalled for Microbial Count
FDA (Food) · 2016-09-14
- ModerateNature Made Vitamin D tablets recalled for yeast and mold
FDA (Food) · 2016-09-14
- ModerateNature Made Vitamin D Tablets Recalled for Yeast and Mold
FDA (Food) · 2016-09-14
- HighNature Made Adult Gummies Multi Recalled for Possible Salmonella Contamination
FDA (Food) · 2016-09-14
- HighNature Made Gummy Multivitamin Recalled for Possible Salmonella Contamination
FDA (Food) · 2016-09-14
Same hazard · yeast mold
See all →- CriticalReBoost nasal spray recalled over yeast, mold and microbial contamination
FDA (Drugs) · 2026-01-14
- CriticalClearLife allergy nasal spray recalled over yeast, mold and microbial contamination
FDA (Drugs) · 2026-01-14
- SevereDurisan Antimicrobial Hand Sanitizer recalled for microbial contamination
FDA (Drugs) · 2021-07-21
- ModerateVistaPharm Recalls Lactulose Solution Due to Microbial Contamination
FDA (Drugs) · 2017-08-09
- SevereVistaPharm Recalls Lactulose Solution Due to Microbial Contamination
FDA (Drugs) · 2017-08-09
Similar recalls
- ModerateNature Made Multivitamin Softgels Recalled Due to Reduced Vitamin Potency
FDA (Food) · 2013-11-27
- ModerateNature Made Multi Vitamins Recalled Due to Reduced Potency
FDA (Food) · 2013-11-27
- ModeratePharmavite Recalls Nature Made Multivitamin Softgels Due to Potency Loss
FDA (Food) · 2013-11-27
- HighVitamin D3 50,000IU Compounded Product Recalled for Sterility Assurance Failure
FDA (Drugs) · 2022-07-20
- SevereRugby D3 Vitamin Liquid Recalled for Yeast and B. cepacia Contamination
FDA (Food) · 2018-01-31
- SevereNatures Pharmacy Recalls Vitamin D Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12